Streetbeat News

Price Targets

RXST

Stifel analyst Thomas Stephan has initiated coverage on RxSight (NASDAQ:RXST) with a Buy rating and set a price target of $40 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:15 am

AVAX-USD

Avalanche (CRYPTO: AVAX) has seen a significant increase in value, rising over 6% in the past 24 hours and 76% over the past week, outperforming the top 20 cryptocurrencies. Coinshares reported $2 million in inflows into Avalanche, and analyst Jacob Canfield expressed a bullish outlook on AVAX. Large transactions have been frequent, and JPMorgan and Apollo's interest in using Avalanche for asset tokenization may be supporting its price. Coincheck recently listed AVAX, and over $275 million in AVAX has been allocated to reward validators, emphasizing the community's commitment to a robust network.

Portfolio Pulse from Khyathi Dalal

December 11, 2023 | 10:25 pm

CMG

DPZ

SBUX

UBER

Benchmark analyst Todd Brooks upgraded Domino's Pizza Inc (NYSE:DPZ) from Hold to Buy with a price target of $455, citing potential growth from a revamped loyalty program and a nationwide launch on Uber Eats. Brooks compared Domino's technology platform favorably with industry leaders like Starbucks and Chipotle. He expects Domino's to achieve over 3% same store sales growth in the U.S. and highlighted management's forecasts for global retail sales and operating income growth. Domino's stock closed up 0.65% at $397.48 on Monday.

Portfolio Pulse from Adam Eckert

December 11, 2023 | 9:50 pm

ITCI

Intra-Cellular Therapies (NASDAQ:ITCI) received 4 analyst ratings in the last quarter, with an average price target of $81.0, representing an upside from the current price of $60.29. The ratings included 1 bullish and 3 somewhat bullish, with no indifferent, somewhat bearish, or bearish ratings. The current average price target has decreased by 1.22% from the previous target of $82.00. Analysts typically review stocks quarterly, basing their ratings on financial statements, meetings, and insider information.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 9:00 pm

AAPL

AMZN

GOOG

GOOGL

Wedbush analyst Dan Ives raised Apple Inc's (AAPL) price target from $240 to $250 and named it the 'Top Tech Pick' for 2024, anticipating it to become the first $4-trillion company. However, Virtus Investment Partners' Joe Terranova believes Alphabet Inc (GOOG, GOOGL) and Amazon.com Inc (AMZN) could outperform Apple in 2024 due to their potential in generative AI, which the market has somewhat overlooked. Cerity Partners' Jim Lebenthal agreed, highlighting Google's Gemini AI and Alphabet's value at 20 times forward earnings. Both analysts expect a rotation of investment into underappreciated mega-cap tech names in the next year.

Portfolio Pulse from Adam Eckert

December 11, 2023 | 8:35 pm

SYRE

Guggenheim has initiated coverage on Spyre Therapeutics (NASDAQ:SYRE) with a Buy rating and set a price target of $44.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 8:33 pm

COGT

Wedbush analyst David Nierengarten has downgraded Cogent Biosciences (COGT) from Outperform to Neutral and reduced the price target from $20 to $5.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 8:30 pm

ADC

APLE

CUBE

DRH

EQR

GLPI

NSA

SHO

VNO

Analysts have downgraded several REITs, potentially signaling a shift in momentum after a strong five-week run. Vornado Realty Trust (VNO) was downgraded by Evercore ISI Group from In-Line to Underperform with a raised price target. National Storage Affiliates Trust (NSA), CubeSmart (CUBE), Equity Residential (EQR), Gaming and Leisure Properties Inc. (GLPI), and Agree Realty Corp. (ADC) also saw downgrades from analysts with various adjustments to their price targets. Additionally, Wells Fargo downgraded three hotel REITs: Apple Hospitality REIT Inc. (APLE), Diamondrock Hospitality Co. (DRH), and Sunstone Hotel Investors Inc. (SHO).

Portfolio Pulse from Ethan Roberts

December 11, 2023 | 8:12 pm

AOS

Citigroup analyst Andrew Kaplowitz has maintained a Neutral rating on A.O. Smith (NYSE:AOS) and increased the price target from $76 to $82.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 8:05 pm

RRX

Regal Rexnord's stock (RRX) has seen an uptick in trading after Wolfe Research upgraded its rating from Peer Perform to Outperform, with a new price target set at $151.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 8:01 pm